Qamar J Khan

8PUBLICATIONS
57CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsTransplantation immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 07, 2025
Randomized Trial of Fixed-Dose Capecitabine Compared With Standard-Dose Capecitabine in Metastatic Breast Cancer: X-7/7 Trial.

Qamar J Khan, Colleen Bohnenkamp, Taylor E Monson

|Mar 11, 2024
Tumor-Infiltrating Lymphocytes Refine Outcomes in Triple-Negative Breast Cancer Treated with Anthracycline-Free Neoadjuvant Chemotherapy.

Miguel Martín, Rachel Yoder, Roberto Salgado

|Mar 06, 2023
ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease.

Shane R Stecklein, Bruce F Kimler, Rachel Yoder

|Dec 01, 2022
Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer.

Julie E Lang, Andres Forero-Torres, Douglas Yee

Pageof 2